FDA Guidance for Industry Pharmacogenomic Data Submissions

Titel:
FDA Guidance for Industry Pharmacogenomic Data Submissions
Herkunft/Verlag:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , https://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm079849.pdf

Dokumentenart:
Guidance for Industry
Inhalt:
Übermittlung pharmacogenomischer Daten bei IND, NDA, BLA

Zurück

GMP Seminare nach Thema